| Dr Aleksandra Mamorska-dyga, MD | |
|
160 N Midland Ave, Nyack, NY 10960-1912 | |
| (845) 348-2000 | |
| Not Available |
| Full Name | Dr Aleksandra Mamorska-dyga |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 19 Years |
| Location | 160 N Midland Ave, Nyack, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467735472 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 267944 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nyack Hospital | Nyack, NY | Hospital |
| Good Samaritan Hospital Of Suffern | Suffern, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| White Plains Medical Diagnostic Services, Pc | 5395918932 | 66 |
News Archive
Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that the U.S. Food and Drug Administration has issued a formal response to the company's 510(k) application.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report that variation in a gene involved in inflammation is associated with developmental problems after preterm birth in females, but not males.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
Certain complications during and immediately after birth are associated with the development of the eating disorders anorexia nervosa and bulimia nervosa, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
› Verified 2 days ago
| Entity Name | Highland Medical P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376600304 PECOS PAC ID: 2668370420 Enrollment ID: O20031230000737 |
News Archive
Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that the U.S. Food and Drug Administration has issued a formal response to the company's 510(k) application.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report that variation in a gene involved in inflammation is associated with developmental problems after preterm birth in females, but not males.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
Certain complications during and immediately after birth are associated with the development of the eating disorders anorexia nervosa and bulimia nervosa, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
› Verified 2 days ago
| Entity Name | Metropolitan Medical Practice Plan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306138383 PECOS PAC ID: 8022286384 Enrollment ID: O20110713000171 |
News Archive
Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that the U.S. Food and Drug Administration has issued a formal response to the company's 510(k) application.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report that variation in a gene involved in inflammation is associated with developmental problems after preterm birth in females, but not males.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
Certain complications during and immediately after birth are associated with the development of the eating disorders anorexia nervosa and bulimia nervosa, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
› Verified 2 days ago
| Entity Name | White Plains Medical Diagnostic Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689955338 PECOS PAC ID: 5395918932 Enrollment ID: O20111027000238 |
News Archive
Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that the U.S. Food and Drug Administration has issued a formal response to the company's 510(k) application.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report that variation in a gene involved in inflammation is associated with developmental problems after preterm birth in females, but not males.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
Certain complications during and immediately after birth are associated with the development of the eating disorders anorexia nervosa and bulimia nervosa, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aleksandra Mamorska-dyga, MD 7516 86th Rd, Woodhaven, NY 11421-1024 Ph: (646) 359-4336 | Dr Aleksandra Mamorska-dyga, MD 160 N Midland Ave, Nyack, NY 10960-1912 Ph: (845) 348-2000 |
News Archive
Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that the U.S. Food and Drug Administration has issued a formal response to the company's 510(k) application.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report that variation in a gene involved in inflammation is associated with developmental problems after preterm birth in females, but not males.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
Certain complications during and immediately after birth are associated with the development of the eating disorders anorexia nervosa and bulimia nervosa, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
› Verified 2 days ago
Pamela Charney, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Adult Hospital Medicine, Nyack Hospital, Nyack, NY 10960 Phone: 845-348-2000 | |
Gerald Abraham Ancheta, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 311 N Midland Ave, Nyack, NY 10960 Phone: 845-358-5006 Fax: 845-358-4340 | |
Dr. Azfar Chak, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 311 N Midland Ave, Nyack, NY 10960 Phone: 845-358-5006 Fax: 845-358-4340 | |
Dr. Boris Melnikau, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-8884 | |
Mr. Jayesh Sampat, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-2000 | |
Mr. Raphael Flowers, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-2000 | |
Smitha Karuthedom, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-2000 |